XAIR Stock Overview
A commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
My Notes
Capture your thoughts, links and company narrative
Beyond Air, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.40 |
| 52 Week High | US$2.36 |
| 52 Week Low | US$0.30 |
| Beta | -0.23 |
| 1 Month Change | -25.35% |
| 3 Month Change | 7.29% |
| 1 Year Change | -81.08% |
| 3 Year Change | -95.88% |
| 5 Year Change | -90.80% |
| Change since IPO | -93.55% |
Recent News & Updates
Recent updates
We're Keeping An Eye On Beyond Air's (NASDAQ:XAIR) Cash Burn Rate
Apr 05
Will Beyond Air (NASDAQ:XAIR) Spend Its Cash Wisely?
Dec 14Beyond Air presents pilot at-home study data; stock earlier snaps 7-day losing streak
Oct 17Beyond Air: Bottom Line Fundamentals Keep Buyers At Bay
Sep 08Beyond Air affiliate Beyond Cancer doses patient in phase 1 study of ultra-high concentration nitric oxide therapy
Aug 23Beyond Air reaches six-month high after $2.3M insider transactions
Jul 06Shareholder Returns
| XAIR | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -13.3% | -1.5% | -2.4% |
| 1Y | -81.1% | 10.0% | 23.4% |
Return vs Industry: XAIR underperformed the US Medical Equipment industry which returned 10% over the past year.
Return vs Market: XAIR underperformed the US Market which returned 23.4% over the past year.
Price Volatility
| XAIR volatility | |
|---|---|
| XAIR Average Weekly Movement | 17.1% |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: XAIR's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: XAIR's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 107 | Steve Lisi | www.beyondair.net |
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through two segments, Beyond Air and Beyond Cancer. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn.
Beyond Air, Inc. Fundamentals Summary
| XAIR fundamental statistics | |
|---|---|
| Market cap | US$29.10m |
| Earnings (TTM) | -US$55.49m |
| Revenue (TTM) | US$2.34m |
12.4x
P/S Ratio-0.5x
P/E RatioIs XAIR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| XAIR income statement (TTM) | |
|---|---|
| Revenue | US$2.34m |
| Cost of Revenue | US$4.63m |
| Gross Profit | -US$2.29m |
| Other Expenses | US$53.20m |
| Earnings | -US$55.49m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.77 |
| Gross Margin | -97.61% |
| Net Profit Margin | -2,369.17% |
| Debt/Equity Ratio | 53.3% |
How did XAIR perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 15:11 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Beyond Air, Inc. is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Gorman | BTIG |
| Marie Thibault | BTIG |
| Matthew Kaplan | Ladenburg Thalmann & Company |